Kerndatensatz Senologie
0.9.0 - ci-build
Kerndatensatz Senologie - Local Development build (v0.9.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "CarePlan",
"id" : "Fall12-Tumorboard",
"meta" : {
"profile" : [
🔗 "https://www.senologie.org/fhir/StructureDefinition/senologie-tumorboard-empfehlung"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CarePlan Fall12-Tumorboard</b></p><a name=\"Fall12-Tumorboard\"> </a><a name=\"hcFall12-Tumorboard\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-senologie-tumorboard-empfehlung.html\">BIH Senologie Tumorboard Empfehlung</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ praeth}\">prätherapeutisch</span></p><p><b>title</b>: Tumorboard-Empfehlung Renate Vogel — ADH B3</p><p><b>description</b>: B3-Läsion (ADH) in Vakuumbiopsie. Nachresektion (offene Biopsie) empfohlen zum Ausschluss eines DCIS oder invasiven Karzinoms. Bei reiner ADH nach Nachresektion: keine weitere Therapie, engmaschige Nachsorge.</p><p><b>subject</b>: <a href=\"Patient-Fall12-Patient-Renate-Vogel.html\">Renate Vogel Female, DoB: 1981-03-06 ( http://fhir.bih-charite.de/sid/patient-id#SENO-2025-012)</a></p><p><b>period</b>: 2025-07-22 --> (ongoing)</p><p><b>addresses</b>: <a href=\"Condition-Fall12-Diagnose-ADH.html\">Condition Neoplasm of uncertain behavior of breast</a></p><blockquote><p><b>activity</b></p><h3>Details</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Kind</b></td><td><b>Code</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td>ServiceRequest</td><td><span title=\"Codes:{http://snomed.info/sct 387713003}\">Offene Biopsie / Nachresektion links OIQ</span></td><td>Scheduled</td></tr></table></blockquote><blockquote><p><b>activity</b></p><h3>Details</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Kind</b></td><td><b>Code</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td>Appointment</td><td><span title=\"Codes:{http://snomed.info/sct 390906007}\">Engmaschige Nachsorge: Mammographie + Sono alle 6 Monate für 2 Jahre</span></td><td>Scheduled</td></tr></table></blockquote></div>"
},
"status" : "active",
"intent" : "plan",
"category" : [
{
"coding" : [
{
"system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
"code" : "praeth",
"display" : "prätherapeutisch"
}
]
}
],
"title" : "Tumorboard-Empfehlung Renate Vogel — ADH B3",
"description" : "B3-Läsion (ADH) in Vakuumbiopsie. Nachresektion (offene Biopsie) empfohlen zum Ausschluss eines DCIS oder invasiven Karzinoms. Bei reiner ADH nach Nachresektion: keine weitere Therapie, engmaschige Nachsorge.",
"subject" : {
🔗 "reference" : "Patient/Fall12-Patient-Renate-Vogel"
},
"period" : {
"start" : "2025-07-22"
},
"addresses" : [
{
🔗 "reference" : "Condition/Fall12-Diagnose-ADH"
}
],
"activity" : [
{
"detail" : {
"kind" : "ServiceRequest",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "387713003",
"display" : "Surgical procedure (procedure)"
}
],
"text" : "Offene Biopsie / Nachresektion links OIQ"
},
"status" : "scheduled"
}
},
{
"detail" : {
"kind" : "Appointment",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "390906007",
"display" : "Follow-up encounter (procedure)"
}
],
"text" : "Engmaschige Nachsorge: Mammographie + Sono alle 6 Monate für 2 Jahre"
},
"status" : "scheduled"
}
}
]
}